Renal Cancer and Inferior Vena Cava Tumor Thrombus
Conditions
Interventions
This is an observational study and does not involve grouping (retrospective and prospective):None
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Patients diagnosed with RCC-IVCTT who visit our center; Patients older than 18 years; Patients or their legal representatives who understand and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: Patients who have not undergone RA-IVCT (Robot-Assisted Inferior Vena Cava Tumor Thrombectomy) surgery; Patients with concurrent malignancies in other systems; IVCTT (Inferior Vena Cava Tumor Thrombus) originating from post-radical surgery tumor bed or recurrent in the vena cava; Patients with bilateral renal tumors; Patients who are lost to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 301 classification for tumor thrombus;Surgical method;Operation time;Blood loss;IVC strategy;Overall survival;Progression-free survival;Morphologic classification of tumor thrombus;Tumor maximum diameter;Tumor side;Tumor pathological type;Tnm staging;Degree of inferior vena cava obstruction;Whether to take targeted drug therapy before operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood serum creatinine;Glutamic-oxalacetic transaminase;Glutamic pyruvic transaminase;Blood urea nitrogen;Gender;Age;Whether combined with diabetes;Whether combined with hypertension;Hemoglobin;Thrombocyte;Body mass index; | — |
Countries
China
Contacts
Public ContactXin Ma
Chinese PLA General Hospital
Outcome results
None listed